[1]
K. K. Khadka, M. Chen, Z. Liu, W. Tong, and D. Wang, “Integrating adverse outcome pathways (AOPs) and high throughput in vitro assays for better risk evaluations, a study with drug-induced liver injury (DILI)”, ALTEX, vol. 37, no. 2, pp. 187–196, Mar. 2020.